Vicus Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $617K | Sell |
5,132
-20
| -0.4% | -$2.31K | 0.05% | 161 |
|
|
2025
Q4 | $542K | Sell |
5,152
-456
| -8% | -$42.8K | 0.04% | 178 |
|
|
2025
Q3 | $471K | Sell |
5,608
-618
| -10% | -$50.9K | 0.04% | 183 |
|
|
2025
Q2 | $493K | Sell |
6,226
-389
| -6% | -$30.9K | 0.04% | 159 |
|
|
2025
Q1 | $594K | Buy |
6,615
+45
| +0.7% | +$4.2K | 0.06% | 125 |
|
|
2024
Q4 | $654K | Sell |
6,570
-41
| -0.6% | -$4.23K | 0.06% | 121 |
|
|
2024
Q3 | $751K | Sell |
6,611
-2,431
| -27% | -$289K | 0.07% | 115 |
|
|
2024
Q2 | $1.12M | Buy |
9,042
+415
| +5% | +$53.5K | 0.1% | 91 |
|
|
2024
Q1 | $1.14M | Buy |
8,627
+2,272
| +36% | +$280K | 0.1% | 88 |
|
|
2023
Q4 | $693K | Sell |
6,355
-2,810
| -31% | -$292K | 0.07% | 111 |
|
|
2023
Q3 | $944K | Buy |
9,165
+2,374
| +35% | +$256K | 0.1% | 94 |
|
|
2023
Q2 | $784K | Sell |
6,791
-364
| -5% | -$41.3K | 0.08% | 103 |
|
|
2023
Q1 | $761K | Sell |
7,155
-23
| -0.3% | -$2.48K | 0.08% | 106 |
|
|
2022
Q4 | $796K | Sell |
7,178
-153
| -2% | -$15.6K | 0.09% | 102 |
|
|
2022
Q3 | $631K | Sell |
7,331
-138
| -2% | -$12.3K | 0.07% | 125 |
|
|
2022
Q2 | $681K | Sell |
7,469
-474
| -6% | -$42K | 0.08% | 123 |
|
|
2022
Q1 | $652K | Buy |
7,943
+1,298
| +20% | +$102K | 0.07% | 131 |
|
|
2021
Q4 | $560K | Buy |
+6,645
| New | +$529K | 0.06% | 141 |
|
|
2021
Q2 | – | Sell |
-7,206
| Closed | -$530K | – | 213 |
|
|
2021
Q1 | $530K | Buy |
7,206
+125
| +2% | +$9.22K | 0.06% | 146 |
|
|
2020
Q4 | $553K | Sell |
7,081
-197
| -3% | -$15.1K | 0.07% | 129 |
|
|
2020
Q3 | $576K | Buy |
7,278
+386
| +6% | +$30.2K | 0.08% | 121 |
|
|
2020
Q2 | $509K | Sell |
6,892
-1,304
| -16% | -$98.2K | 0.08% | 120 |
|
|
2020
Q1 | $602K | Sell |
8,196
-188
| -2% | -$14.8K | 0.11% | 99 |
|
|
2019
Q4 | $728K | Sell |
8,384
-11,112
| -57% | -$913K | 0.11% | 103 |
|
|
2019
Q3 | $1.57M | Buy |
19,496
+4,865
| +33% | +$390K | 0.22% | 73 |
|
|
2019
Q2 | $1.17M | Sell |
14,631
-138
| -0.9% | -$10.6K | 0.16% | 94 |
|
|
2019
Q1 | $1.17M | Sell |
14,769
-76
| -0.5% | -$5.68K | 0.19% | 86 |
|
|
2018
Q4 | $1.08M | Buy |
14,845
+284
| +2% | +$20K | 0.19% | 87 |
|
|
2018
Q3 | $986K | Sell |
14,561
-329
| -2% | -$21K | 0.16% | 92 |
|
|
2018
Q2 | $862K | Sell |
14,890
-398
| -3% | -$22.5K | 0.14% | 105 |
|
|
2018
Q1 | $795K | Sell |
15,288
-693
| -4% | -$37.4K | 0.14% | 115 |
|
|
2017
Q4 | $858K | Buy |
15,981
+440
| +3% | +$24.4K | 0.15% | 106 |
|
|
2017
Q3 | $950K | Buy |
15,541
+5,782
| +59% | +$351K | 0.18% | 94 |
|
|
2017
Q2 | $597K | Buy |
9,759
+91
| +0.9% | +$5.54K | 0.12% | 129 |
|
|
2017
Q1 | $586K | Sell |
9,668
-3,357
| -26% | -$204K | 0.13% | 133 |
|
|
2016
Q4 | $732K | Buy |
13,025
+374
| +3% | +$21.9K | 0.16% | 115 |
|
|
2016
Q3 | $753K | Buy |
12,651
+257
| +2% | +$15K | 0.17% | 112 |
|
|
2016
Q2 | $681K | Buy |
12,394
+739
| +6% | +$39.3K | 0.17% | 102 |
|
|
2016
Q1 | $588K | Buy |
11,655
+39
| +0.3% | +$1.91K | 0.13% | 103 |
|
|
2015
Q4 | $585K | Buy |
11,616
+53
| +0.5% | +$2.67K | 0.15% | 103 |
|
|
2015
Q3 | $545K | Buy |
11,563
+48
| +0.4% | +$2.55K | 0.14% | 99 |
|
|
2015
Q2 | $626K | Sell |
11,515
-598
| -5% | -$33.5K | 0.16% | 103 |
|
|
2015
Q1 | $664 | Hold |
12,113
| – | – | 0.13% | 93 |
|
|
2014
Q4 | $656K | Sell |
12,113
-725
| -6% | -$40.4K | 0.19% | 87 |
|
|
2014
Q3 | $726K | Buy |
12,838
+4,539
| +55% | +$255K | 0.24% | 69 |
|
|
2014
Q2 | $458K | Buy |
8,299
+105
| +1% | +$5.73K | 0.15% | 84 |
|
|
2014
Q1 | $444K | Buy |
8,194
+889
| +12% | +$46K | 0.15% | 84 |
|
|
2013
Q4 | $349K | Buy |
+7,305
| New | +$334K | 0.13% | 84 |
|
Other funds holding MRK
VCM
VPM
Vicus Capital's MRK Position: Q1 2026 in Review
Vicus Capital reduced its Merck (MRK) stake by 0.39% in Q1 2026, selling an estimated $2.31K and leaving 5,132 shares worth $617K. The position accounts for 0.05% of the portfolio, ranked #161.
Vicus Capital first reported a position in MRK in Q4 2013 and has held it in 48 quarters since. The position peaked at $1.57M in Q3 2019. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Vicus Capital held 5,132 shares of Merck worth $617K as of Q1 2026.
- Vicus Capital sold 20 Merck shares in Q1 2026, an estimated $2.31K.
- Merck made up 0.05% of Vicus Capital's portfolio in Q1 2026, its #161 holding.
- Vicus Capital first reported a position in Merck in Q4 2013 and has held it in 48 quarters since.
- Vicus Capital's Merck position peaked at $1.57M in Q3 2019.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Vicus Capital's 13F filing for Q1 2026, filed 22 Apr 2026.